Analysis of safety of bioactive concentrate of small sea fish therapy in comorbid patients with osteoarthritis
The article discusses the safety issues of a bioactive concentrate of small sea fish (BCSSF, Alflutop®) in the treatment of osteoarthritis (OA). The data of original studies, which were published during 2001–2021 years, from eLIBRARY, PubMed and Web of Science databases were analyzed. The selection...
Saved in:
Main Authors: | O. V. Zimnitskaya, M. M. Petrova, P. A. Shesternya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2021-06-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1157 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioactive concentrate from small sea fish: evaluation of the efficacy and safety of the drug on the basis of the analysis of 37 clinical trials
by: A. E. Karateev
Published: (2020-11-01) -
Chronic back pain as a spinal osteoarthritis manifestation: rationale and practice of symptomatic slow acting drugs for osteoarthritis use
by: A. E. Karateev
Published: (2022-08-01) -
Results of an open multicenter non-interventional study of clinical efficacy and tolerability of etoricoxib in osteoarthritis and nonspecific back pain with additional evaluation of the effect of the drug on the «central» manifestations of pain
by: A. E. Karateev, et al.
Published: (2022-05-01) -
Central muscle relaxants in rheumatology practice
by: E. Yu. Polishchuk, et al.
Published: (2021-12-01) -
GENERAL PRINCIPLES OF TREATMENT FOR MUSCULOSKELETAL PAIN: INTERDISCIPLINARY CONSENSUS
by: E. L. Nasonov, et al.
Published: (2016-07-01)